Skip to main content

Affordability Check

How to afford Lamotrigine Extended-Release

Generic name: lamotrigine extended-release

Pick how you're covered. We'll show you the cheapest legitimate way to get Lamotrigine Extended-Release — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.

How are you covered for prescriptions?

Pick the one that fits you. We'll show you the cheapest way to get this drug.

Pick an option above to see your specific path.

Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.

About Lamotrigine Extended-Release and its cost

What is this medication? Lamotrigine extended-release is a prescription medication primarily used as an anticonvulsant or antiepileptic drug. It is specifically approved to treat certain types of seizures in adults and children who are at least thirteen years old. These include partial-onset seizures, with or without secondary generalization, and primary generalized tonic-clonic seizures. The medication works by stabilizing electrical activity in the brain to prevent the onset and spread of seizure activity.

Unlike the immediate-release version, the extended-release formulation is designed to be taken once daily because it releases the active ingredient slowly into the bloodstream over a twenty-four-hour period. This helps maintain a more consistent level of the drug in the body, which can reduce the frequency of doses and potentially lower the risk of side effects associated with peak levels. It is often used as either a primary treatment or an add-on therapy alongside other seizure medications to achieve better control over neurological symptoms.

Lamotrigine Extended-Release is made by GlaxoSmithKline. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.

Common questions

What's the cheapest way to afford Lamotrigine Extended-Release?

It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.

Can I use a copay card with Medicare for Lamotrigine Extended-Release?

No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But GlaxoSmithKline has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.

Does my Medicare Part D plan cover Lamotrigine Extended-Release?

Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.

How long does a Patient Assistance Program take?

Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.

What if I have a high-deductible plan?

For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.

Are there charity grants for Epilepsy?

Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.

More about Lamotrigine Extended-Release